• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

UMEZU Tomokazu  梅津 朋和

ORCIDConnect your ORCID iD *help
Researcher Number 20467319
Affiliation (based on the past Project Information) *help 2013: 名古屋大学, 医学部附属病院, 助教
2012: 名古屋大学, 医学(系)研究科(研究院), 助教
2010 – 2012: 名古屋大学, 医学系研究科, 助教
2008 – 2009: Nagoya University, 大学院・医学系研究科, 助教
Review Section/Research Field
Principal Investigator
Obstetrics and gynecology
Keywords
Principal Investigator
卵巣癌 / 予後 / Glypican-3 / 明細胞腺癌 / SPHK1 / IL6 / PBMC / 免疫療法 / グリピカン3 / GC33 … More / IGF-II / 抗体療法 / アポトーシス / sh RNA / 早期 / in vivo / タキソール / Glypican 3 Less
  • Research Projects

    (3 results)
  • Research Products

    (50 results)
  •  難治性卵巣癌における癌周辺微小環境を標的とした新規治療法の確立Principal Investigator

    • Principal Investigator
      梅津 朋和
    • Project Period (FY)
      2013 – 2016
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Nagoya University
  •  New therapeutic strategy for refractory ovarian carcinoma based on function of Glypican-3Principal Investigator

    • Principal Investigator
      UMEZU Tomokazu
    • Project Period (FY)
      2010 – 2012
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Nagoya University
  •  Establish of molecular target therapy for Glypican-3 in ovarian clear cell carcinomaPrincipal Investigator

    • Principal Investigator
      UMEZU Tomokazu
    • Project Period (FY)
      2008 – 2009
    • Research Category
      Grant-in-Aid for Young Scientists (Start-up)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Nagoya University

All 2014 2013 2012 2011 2010 2009

All Journal Article Presentation

  • [Journal Article] Survival benefit of taxane plus platinum in recurrent ovarian cancer with non-clear cell, non-mucinous histology.2014

    • Author(s)
      Kajiyama H, Shibata K, Mizuno M, Umezu T, Suzuki S, Sekiya R, Niimi K, Mitsui H, Yamamoto E, Kawai M, Nagasaka T, Kikkawa F.
    • Journal Title

      Journal of gynecologic oncology.

      Volume: 25 Pages: 43-50

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25861486
  • [Journal Article] Is There Any Association between Where Patients Spend the End of Life and Survival after Anticancer Treatment for Gynecologic Malignancy?2014

    • Author(s)
      Kajiyama H, Utsumi F, Higashi M, Sakata J, Sekiya R, Mizuno M, Umezu T, Suzuki S, Yamamoto E, Mitsui H, Niimi K, Shibata K, Kikkawa F.
    • Journal Title

      Journal of palliative medicine

      Volume: 17 Pages: 325-30

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25861486
  • [Journal Article] The expression and characterization of endoglin in uterine leiomyosarcoma.2013

    • Author(s)
      Mitsui H, Shibata K, Mano Y, Suzuki S, Umezu T, Mizuno M, Yamamoto E, Kajiyama H, Kotani T, Senga T, Kikkawa F.
    • Journal Title

      Clinical & experimental metastasis.

      Volume: 30 Pages: 731-40

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25861486
  • [Journal Article] The expression and characterization of endoglin in uterine leiomyosarcoma.2013

    • Author(s)
      Mitsui H, Shibata K, Mano Y, Suzuki S, Umezu T, Mizuno M, Yamamoto E, Kajiyama H, Kotani T, Senga T, Kikkawa F.
    • Journal Title

      Clin Exp Metastasis

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement2013

    • Author(s)
      Kajiyama H, Shibata K, Umezu T, Mizuno M, Suzuki S, Yamamoto E, Fujiwara S, Kikkawa F
    • Journal Title

      Hum Pathol

      Volume: 44 Pages: 181-8

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement.2013

    • Author(s)
      Kajiyama H, Shibata K, Umezu T, Mizuno M, Suzuki S, Yamamoto E, Fujiwara S, Kikkawa F.
    • Journal Title

      Hum Pathol.

      Volume: 44(2) Pages: 181-188

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement.2013

    • Author(s)
      Kajiyama H, Shibata K, Umezu T, Mizuno M, Suzuki S, Yamamoto E, Fujiwara S, Kikkawa F.
    • Journal Title

      Human pathology.

      Volume: 44 Pages: 181-8

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25861486
  • [Journal Article] Is there any association between retroperitoneal lymphadenectomy and survival benefit in advanced stage epithelial ovarian carcinoma patients2012

    • Author(s)
      Sakai K, Kajiyama H, Umezu T, Shibata K, Mizuno M, Suzuki S, Kawai M, Nagasaka T, Kikkawa F.
    • Journal Title

      J Obstet Gynaecol Res

      Volume: 38 Pages: 1018-23

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Prognostic factors in stage IA-IIA cervical cancer patients treated surgically: does the waiting time to the operation affect survival?2012

    • Author(s)
      Umezu T, Shibata K, Kajiyama H, Yamamoto E, Mizuno M, Kikkawa F.
    • Journal Title

      Arch Gynecol Obstet.

      Volume: 285(2) Pages: 493-497

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in malignant germ cell tumors of the ovary2012

    • Author(s)
      Trinh DT, Shibata K, Hirosawa T, Umezu T, Mizuno M, Kajiyama H, Kikkawa F
    • Journal Title

      J Obstet Gynaecol Res

      Volume: 35 Pages: 841-8

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Expression of CXCR4 indicates poor prognosis in patients with clear cell carcinoma of the ovary2012

    • Author(s)
      Sekiya R, Kajiyama H, Sakai K, Umezu T, Mizuno M, Shibata K, Yamamoto E, Fujiwara S, Nagasaka T, Kikkawa F
    • Journal Title

      Hum Pathol

      Volume: 43 Pages: 904-10

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Postrecurrent oncologic outcome of patients with ovarian clear cell carcinoma.2012

    • Author(s)
      Kajiyama H, Shibata K, Mizuno M, Yamamoto E, Fujiwara S, Umezu T, Suzuki S, Nakanishi T, Nagasaka T, Kikkawa F
    • Journal Title

      Int J Gynecol Cancer.

      Volume: 22(5) Pages: 801-806

    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Postrecurrent oncologic outcome of patients with ovarian clear cell carcinoma2012

    • Author(s)
      Kajiyama H, Shibata K, Mizuno M, Yamamoto E, Fujiwara S, Umezu T, Suzuki S, Nakanishi T, Nagasaka T, Kikkawa F
    • Journal Title

      Int J Gynecol Cancer

      Volume: 22 Pages: 801-6

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Functional interaction between peritoneal mesothelial cells and stem cells of ovarian yolk sac tumor (SC-OYST) in peritoneal dissemination2012

    • Author(s)
      Mitsui H, Shibata K, Suzuki S, Umezu T, Mizuno M, Kajiyama H, Kikkawa F
    • Journal Title

      Gynecologic oncology

      Volume: 124(2) Pages: 303-310

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Functional interaction between peritoneal mesothelial cells and stem cells of ovarian yolk sac tumor (SC-OYST) in peritoneal dissemination2012

    • Author(s)
      Mitsui H, Shibata K, Suzuki S, Umezu T, Mizuno M, Kajiyama H, Kikkawa F
    • Journal Title

      Gynecol Oncol

      Volume: 124 Pages: 303-10

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Long-term clinical outcome of patients with recurrent epithelial ovarian carcinoma: is it the same for each histological type2012

    • Author(s)
      Kajiyama H, Shibata K, Mizuno M, Umezu T, Suzuki S, Yamamoto E, Fujiwara S, Kawai M, Nagasaka T, Kikkawa F
    • Journal Title

      Int J Gynecol Cancer

      Volume: 22 Pages: 394-9

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Is there any association between retroperitoneal lymphadenectomy and survival benefit in advanced stage epithelial ovarian carcinoma patients?2012

    • Author(s)
      Sakai K, Kajiyama H, Umezu T, Shibata K, Mizuno M, Suzuki S, Kawai M, Nagasaka T, Kikkawa F.
    • Journal Title

      J Obstet Gynaecol Res.

      Volume: 38(7) Pages: 1018-1023

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Expression of CXCR4 indicates poor prognosis in patients with clear cell carcinoma of the ovary2012

    • Author(s)
      Sekiya R, Kajiyama H, Sakai K, Umezu T, Mizuno M, Shibata K, Yamamoto E, Fujiwara S, Nagasaka T, Kikkawa F
    • Journal Title

      Human pathology

      Volume: (printing)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Prognostic factors in stage IA-IIA cervical cancer patients treated surgically: does the waiting time to the operation affect survival?2012

    • Author(s)
      Umezu T, Shibata K, Kajiyama H, Yamamoto E, Mizuno M, Kikkawa F
    • Journal Title

      Arch Gynecol Obstet.

      Volume: 285 Pages: 493-7

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Prognostic factors in stage IA-IIA cervical cancer patients treated surgically : does the waiting time to the operation affect survival?2012

    • Author(s)
      Umezu T, Shibata K, Kajiyama H, Yamamoto E, Mizuno M, Kikkawa F
    • Journal Title

      Archives of gynecology and obstetrics

      Volume: 285(2) Pages: 493-497

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Establishment of cisplatin-resistant ovarian yolk sac tumor cells and investigation of the mechanism of cisplatin resistance using this cell line.2011

    • Author(s)
      Shibata K, Umezu T, Sakurai M, Kajiyama H, Yamamoto E, Ino K, Nawa A, Kikkawa F
    • Journal Title

      Gynecol Obstet Invest

      Volume: 71 Pages: 104-11

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Strong antibody reaction against glycosphingolipids injected in liposome-embedded forms in beta3GN-T5 knockout mice2011

    • Author(s)
      Fan X, Kondo Y, Tokuda N, Ohmi Y, Ando R, Umezu T, Zhang Q, Furukawa K, Shibata K, Togayachi A, Narimatsu H, Okajima T, Kikkawa K, Furukawa K
    • Journal Title

      Nagoya J Med Sci

      Volume: 73 Pages: 137-46

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary2010

    • Author(s)
      Umezu T, Shibata K, Kajiyama H, Yamamoto E, Nawa A, Kikkawa F
    • Journal Title

      J Clin Pathol

      Volume: 63 Pages: 962-6

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Gene silencing of glypican-3 in clear cell carcinoma of the ovary renders it more sensitive to the apoptotic agent paclitaxel in vitro and in vivo.2010

    • Author(s)
      Umezu T, Shibata K, Shimaoka M, Kajiyama H, Yamamoto E, Ino K, Nawa A, Senga T, Kikkawa F.
    • Journal Title

      Cancer science 101

      Pages: 143-8

    • NAID

      10027199881

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20890099
  • [Journal Article] Assessment of the predictive value of follicular fluid insulin, leptin and adiponectin in assisted reproductive cycles.2010

    • Author(s)
      Takikawa S, Iwase A, Goto M, Harata T, Umezu T, Nakahara T, Kobayashi H,Suzuki K, Manabe S, Kikkawa F.
    • Journal Title

      Gynecol Endocrinol

      Volume: 26 Pages: 494-9

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Gene silencing of glypican-3 in clear cell carcinoma of the ovary renders it more sensitive to the apoptotic agent paclitaxel in vitro and in vivo.2010

    • Author(s)
      Umezu T, Shibata K, Shimaoka M, Kajiyama H, Yamamoto E, Ino K, Nawa A, Senga T, Kikkawa F.
    • Journal Title

      Cancer Sci 101(1)

      Pages: 143-148

    • NAID

      10027199881

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20890099
  • [Journal Article] Identification and characterization of cancer stem cells in ovarian yolk sac tumors.2010

    • Author(s)
      Suzuki S, Terauchi M, Umezu T, Kajiyama H, Shibata K, Nawa A, Kikkawa F
    • Journal Title

      Cancer Sci

      Volume: 101 Pages: 2179-85

    • NAID

      10027832399

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary.2010

    • Author(s)
      Umezu T, Shibata K, Kajiyama H, et al.
    • Journal Title

      Journal of clinical pathology

      Volume: 63 Pages: 962-6

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Growth-suppressing function of glypican-3 (GPC3) via insulin like growth factor II (IGF-II) signaling pathway in ovarian clear cell carcinoma cells.2010

    • Author(s)
      Sakurai M, Shibata K, Umezu T, Kajiyama H, Yamamoto E, Ino K, Nawa A, Kikkawa F.
    • Journal Title

      Gynecol Oncol

      Volume: 119 Pages: 332-6

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Three-dimensional CT angiography is useful for diagnosis of postabortion uterine hemorrhage: 3 case reports and review of the literature.2010

    • Author(s)
      Umezu T, Iwase A, Ota T, Suzuki K, Nakagawa A, Nakahara T, Takikawa S, Kobayashi H, Manabe S, Suzuki K, Goto M, Kikkawa F
    • Journal Title

      J Minim Invasive Gynecol.

      Volume: 17 Pages: 246-51

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Journal Article] Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy.2010

    • Author(s)
      Inaba T, Ino K, Kajiyama H, Shibata K, Yamamoto E, Kondo S, Umezu T, Nawa A, Takikawa O, Kikkawa F.
    • Journal Title

      Gynecol Oncol

      Volume: 117 Pages: 423-8

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Presentation] 卵巣明細胞腺癌を対象とした GPC3 特異的ペプチドワクチン療法の臨床第I、II 相試験の中間報告2012

    • Author(s)
      柴田清住、鈴木史朗、藤原多子、梅津朋和、山本英子、梶山広明、水野美香、吉川史隆
    • Organizer
      第52回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      東京 グランドプリンスホテル新高輪
    • Year and Date
      2012-07-19
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Presentation] 卵巣明細胞腺癌を対象とした Glypican-3 ペプチドワクチン療法における免疫的モニタリング2012

    • Author(s)
      鈴木史朗、柴田清住、芳川修久、足立学、山田英里、関谷龍一郎、三井寛子、熊澤詔子、梅津朋和、水野美香、梶山広明、吉川史隆、中面哲也
    • Organizer
      第52回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      東京 グランドプリンスホテル新高輪
    • Year and Date
      2012-07-29
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Presentation] 卵巣明細胞腺癌を対象とした GPC3 特異的ペプチドワクチン療法の臨床第I、II 相試験2012

    • Author(s)
      柴田清住、鈴木史朗、梶山広明、水野美香、梅津朋和、吉川史隆
    • Organizer
      第64回日本産科婦人科学会学術講演会
    • Place of Presentation
      神戸 神戸国際展示場
    • Year and Date
      2012-04-13
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Presentation] 卵巣明細胞腺癌を対象としたGlypican-3ペプチドワクチン療法における免疫的モニタリング2012

    • Author(s)
      鈴木史朗、柴田清住、芳川修久、足立学、山田英里、関谷龍一郎、三井寛子、熊澤詔子、梅津朋和、水野美香、梶山広明、吉川史隆、中面哲也
    • Organizer
      第52回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      東京 グランドプリンスホテル新高輪
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Presentation] 卵巣明細胞腺癌を対象としたGPC3特異的ペプチドワクチン療法の臨床第I、II相試験の中間報告2012

    • Author(s)
      柴田清住、鈴木史朗、藤原多子、梅津朋和、山本英子、梶山広明、水野美香、吉川史隆
    • Organizer
      第52回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      東京 グランドプリンスホテル新高輪
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Presentation] 早期の明細胞腺癌では Glypican-3 発現は予後不良因子となりうる。2011

    • Author(s)
      梅津朋和、柴田清住、梶山広明、那波明宏、吉川史隆
    • Organizer
      第50回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      札幌 札幌コンベンションセンター
    • Year and Date
      2011-07-22
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Presentation] 早期の明細胞腺癌ではGlypican-3発現は予後不良因子となりうる2011

    • Author(s)
      梅津朋和、柴田清住、梶山広明、水野美香、那波明宏、吉川史隆
    • Organizer
      第63回日本産科婦人科学会学術講演会
    • Place of Presentation
      大阪
    • Year and Date
      2011-08-29
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Presentation] 卵巣明細胞腺癌における Glypican-3 ペプチドワクチン療法の基礎的検討2011

    • Author(s)
      鈴木史朗、柴田清住、山田英里、関谷龍一郎、松村寛子、堀尾麻衣子、梅津朋和、水野美香、梶山広明、那波明宏、吉川聡明、中面哲也、吉川史隆
    • Organizer
      第50回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      札幌 札幌コンベンションセンター
    • Year and Date
      2011-07-22
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Presentation] 早期の明細胞腺癌では Glypican-3 発現は予後不良因子となりうる。2011

    • Author(s)
      梅津朋和、柴田清住、梶山広明、那波明宏、吉川史隆
    • Organizer
      第63回日本産科婦人科学会学術講演会
    • Place of Presentation
      大阪 大阪国際会議場
    • Year and Date
      2011-08-29
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Presentation] 卵巣明細胞腺癌におけるGlypican-3ペプチドワクチン療法の基礎的検討2011

    • Author(s)
      鈴木史朗、柴田清住、山田英里、関谷龍一郎、松村寛子、堀尾麻衣子、梅津朋和、水野美香、梶山広明、那波明宏、吉川聡明、中面哲也、吉川史隆
    • Organizer
      第50回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      札幌
    • Year and Date
      2011-07-22
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Presentation] 早期の明細胞腺癌ではGlypican-3発現は予後不良因子となりうる2010

    • Author(s)
      梅津朋和
    • Organizer
      第48回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      つくば国際会議場
    • Year and Date
      2010-07-08
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Presentation] Glypican-3(GPC3)ノックダウンによる卵巣明細胞腺癌のパクリタキセル耐性克服2010

    • Author(s)
      柴田清住、梅津朋和、櫻井麻衣子、梶山広明、那波明宏、吉川史隆
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪 大阪国際会議場
    • Year and Date
      2010-09-22
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Presentation] Glypican3の卵巣明細胞腺癌における増殖制御と作用機序の検討2010

    • Author(s)
      櫻井麻衣子、柴田清住、境康太郎、関谷龍一郎、熊澤詔子、三井寛子、藤原多子、梅津朋和、梶山広明、那波明宏、吉川史隆
    • Organizer
      第63回日本産科婦人科学会学術講演会
    • Place of Presentation
      東京
    • Year and Date
      2010-04-23
    • Data Source
      KAKENHI-PROJECT-20890099
  • [Presentation] 卵巣明細胞腺癌における Glypican-3 の腫瘍増殖抑制の検討2010

    • Author(s)
      櫻井麻衣子、柴田清住、関谷龍一郎、松村寛子、境康太郎、廣澤友也、藤原多子、梅津朋和、梶山広明、那波明宏、吉川史隆
    • Organizer
      第48回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      筑波 つくば国際会議場
    • Year and Date
      2010-07-08
    • Data Source
      KAKENHI-PROJECT-22791526
  • [Presentation] Glypican 3抑制による卵巣明細胞腺癌のタキソール感受性の増強について2009

    • Author(s)
      梅津朋和、柴田清住、鈴木史朗、藤原多子、塚本裕久、寺内幹雄、梶山広明、那波明宏、吉川史隆
    • Organizer
      第62回日本産科婦人科学会学術講演会
    • Place of Presentation
      京都
    • Year and Date
      2009-04-04
    • Data Source
      KAKENHI-PROJECT-20890099
  • [Presentation] Glypican3抑制による卵巣明細胞腺癌のタキソール感受性の増強について2009

    • Author(s)
      梅津朋和
    • Organizer
      日本産科婦人科学会学術講演会
    • Place of Presentation
      京都
    • Year and Date
      2009-04-04
    • Data Source
      KAKENHI-PROJECT-20890099
  • [Presentation] 卵巣明細胞腺癌におけるGlypican 3抑制によるタキソール感受性の増強について2009

    • Author(s)
      梅津朋和
    • Organizer
      NAGOYAグローバルリトリード
    • Place of Presentation
      愛知県 大府市あいち健康プラザ
    • Year and Date
      2009-02-20
    • Data Source
      KAKENHI-PROJECT-20890099
  • [Presentation] Glypican3抑制による卵巣明細胞腺癌のタキソール感受性の増強にっいて2009

    • Author(s)
      梅津朋和
    • Organizer
      日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      新潟
    • Year and Date
      2009-07-10
    • Data Source
      KAKENHI-PROJECT-20890099
  • [Presentation] Glypican 3抑制による卵巣明細胞腺癌のタキソール感受性の増強について2009

    • Author(s)
      梅津朋和、柴田清住、鈴木史朗、藤原多子、塚本裕久、寺内幹雄、梶山広明、那波明宏、吉川史隆
    • Organizer
      第46回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      新潟
    • Year and Date
      2009-07-10
    • Data Source
      KAKENHI-PROJECT-20890099

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi